Avacta : Preliminary Results for the year ended 31 December

A period of continued significant progress



Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to... | April 25, 2023

Related Keywords

United States , New York , London , City Of , United Kingdom , Ireland , Germany , Florida , Cambridge , Cambridgeshire , Glasgow , Glasgow City , France , Sweden , South Korea , Manchester , China , American , Chinese , America , South Korean , Korea , Mike Owen , Alastair Smith , Eliot Forster , Genscript Probio , Tony Gardiner , Christina Coughlin , Revenues For The Therapeutics Division , American Association For Cancer Research , Animal Health Division , Group Diagnostics Division , Cytoimmune Therapeutics Inc , Bonds , Fred Hutchinson Cancer Center , Imperial College White City Campus , Daewoong Pharmaceuticals , Company Phase , Therapeutics Division , Rubius Therapeutics Inc , Lg Chem Life Sciences , Safety Data Monitoring Committee , Diagnostics Division , Regulatory Agency , Korean Lg Group , Group Diagnostics , Tmunity Therapeutics Inc , Drug Administration , Whilst The Company , Animal Health Division To Vimian Group , Diagnostics Holdings Ltd Launch , American Association For Cancer Research Annual Meeting , Company Affimer , American Cancer Society , Avacta Animal Health , Avacta Therapeutics Division , Memorial Sloane Kettering Cancer Center , Vimian Group , Avacta Diagnostics Division , Foundation Trust In Manchester , Animal Health , Affyxell Therapeutics Co Ltd , Clinical Technology Solution Center , Revenues For The Diagnostics Division , Biopharma Inc , Avacta Group , Avacta Employee Share , Registrar Of Companies , Drug Development Collaborations , Heights Capital Ireland , American Association , Cancer Research , Orphan Drug Designation , Investigational New Drug Application , Xell Therapeutics , Daewoong Pharmaceutical , Korea Non Clinical Technology Solution Center , Life Sciences , Scale Space , Imperial College , White City Campus , Science Day , Launch Diagnostics , Chief Executive Officer , Cytoimmune Therapeutics , Non Executive Director , Cancer Research Annual , Avacta Diagnostics , Diagnostic Divisions , Rubius Therapeutics , Tmunity Therapeutics , White City , Scientific Advisory Board , Royal Marsden , Investigational New Drug , Clinical Trial Authorisation , Annual Meeting , Host Disease , Launch Diagnostics Holdings Ltd , Launch Diagnostic , Consolidated Statement , Financial Position , Alternative Performance Measures , Year Ended , Preliminary Results , Companies Act , Annual General , Avacta Employee Share Trust , Avacta Share Incentive Plan , Avacta Group Plc Stock Exchange , News , Information , Press Release , , Eriod , F , Ontinued , Significant , Avacta , Group , Lc , Life , Ciences , Company , Developing , Argeted , Ncology , Drugs , End , Powerful , Us , Leased Avct Gb00byyw9g87 ,